Get started

Financials · SBRA

Sabra Health Care REIT Inc. (SBRA) financials

For the twelve months ended Sep 30, 2026, Sabra Health Care REIT Inc. reported $919.09M of revenue and $71.51M of net income.

Revenue, TTM
$919.09M
Revenue growth, YoY
+23.4%
Net income, TTM
$71.51M
Net income growth, YoY
-59.2%
Net margin
7.8%
EPS, diluted, TTM
$0.28
EPS growth, YoY
-61.6%
Cash
$36.24M
Total debt
$2.44B
P/E
76.98
P/S
5.99
Market cap
$5.51B
Annual revenue$774.63M
FY2016FY2025
Annual net income$155.61M
FY2016FY2025

SBRA revenue and earnings growth

SBRA revenueQ3 2026$249.56M

Quarter YoY
+31.3%
QoQ
+5.8%
FY YoY
+10.2%
5Y CAGR
+5.3%
10Y CAGR
+12.5%

SBRA revenue was $249.56M in fiscal Q3 2026 (ended Sep 30, 2026), up 31.3% from a year earlier and up 5.8% from the prior quarter. For the full fiscal 2025 it was $774.63M, up 10.2% from fiscal 2024. Compound annual growth was +5.3% over 5 years and +12.5% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

SBRA net incomeQ3 2026$28.61M

Quarter YoY
+26.9%
FY YoY
+22.8%
5Y CAGR
+2.4%
10Y CAGR
+7.0%

SBRA net income was $28.61M in fiscal Q3 2026 (ended Sep 30, 2026), up 26.9% from a year earlier. For the full fiscal 2025 it was $155.61M, up 22.8% from fiscal 2024. Compound annual growth was +2.4% over 5 years and +7.0% over 10 years.

SBRA EPSQ3 2026$0.11

Quarter YoY
+22.2%
FY YoY
+18.5%
5Y CAGR
-0.9%

SBRA diluted EPS was $0.11 in fiscal Q3 2026 (ended Sep 30, 2026), up 22.2% from a year earlier. For the full fiscal 2025 it was $0.64, up 18.5% from fiscal 2024. Compound annual growth was -0.9% over 5 years.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$774.63M$703.24M$647.51M$624.81M$569.54M$598.57M$661.74M$623.41M$408.28M$260.53M
Selling, general and admin$53.71M$50.07M$47.47M$39.57M$34.67M$32.76M$30.89M$37.09M$32.40M$17.67M
Pre-tax income$153.42M$128.11M$18.66M$21.67M$80.67M$155.73M$79.22M$287.56M$159.02M$71.25M
Income tax$1.84M$1.00M$2.00M$1.24M$1.84M$710.0K$3.40M$3.01M$651.0K$1.05M
Net income$155.61M$126.71M$13.76M-$77.61M-$113.26M$138.42M$69.00M$279.08M$158.38M$70.28M
EPS, basic$0.64$0.54$0.06-$0.34-$0.52$0.67$0.37$1.51$1.40$0.92
EPS, diluted$0.64$0.54$0.06-$0.34-$0.52$0.67$0.37$1.51$1.40$0.92
Diluted shares244.5M236.0M232.8M230.9M219.1M207.3M188.1M178.7M105.8M65.5M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$71.54M$66.34M$46.72M$53.93M$115.89M$65.52M$49.14M$59.66M$587.45M$34.66M
Total assets$5.49B$5.30B$5.39B$5.75B$5.97B$5.99B$6.07B$6.67B$7.03B$2.27B
Total debt$2.53B$2.42B$2.41B$2.51B$2.39B$2.37B$2.40B$3.23B$3.39B$1.21B
Total liabilities$2.67B$2.56B$2.58B$2.69B$2.59B$2.58B$2.58B$3.41B$3.60B$1.25B
Shareholders' equity$2.82B$2.74B$2.80B$3.06B$3.38B$3.41B$3.49B$3.25B$3.44B$1.02B

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow$348.61M$310.54M$300.57M$315.73M$356.39M$354.85M$372.48M$360.59M$135.79M$175.93M
Investing cash flow-$377.96M-$109.00M$103.13M-$216.25M-$336.20M-$136.45M$262.84M-$258.49M-$182.56M$142.36M
Financing cash flow$40.76M-$181.56M-$410.30M-$161.71M$30.14M-$202.11M-$646.18M-$629.34M$598.82M-$300.90M
Dividends paid$289.50M$280.15M$277.45M$277.16M$262.92M$278.30M$335.44M$325.22M$182.09M$119.26M
Stock-based compensation$11.36M$8.99M$7.92M$7.45M$7.91M$7.91M$9.82M$7.65M$8.36M$7.50M
Depreciation and amortization$187.00M$169.62M$183.09M$187.78M$178.99M$176.74M$181.55M$191.38M$113.88M$68.47M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY10.2%8.6%3.6%9.7%-4.8%-9.5%6.1%52.7%56.7%9.1%
Net income growth, YoY22.8%821.1%---100.6%-75.3%76.2%125.4%-11.5%
EPS growth, YoY18.5%800.0%---81.1%-75.5%---17.1%
Net margin20.1%18.0%2.1%-12.4%-19.9%23.1%10.4%44.8%38.8%27.0%
Return on equity5.5%4.6%0.5%-2.5%-3.4%4.1%2.0%8.6%4.6%6.9%
Return on assets2.8%2.4%0.3%-1.4%-1.9%2.3%1.1%4.2%2.3%3.1%
Debt to equity0.900.880.860.820.710.700.690.990.991.19

Source: XBRL data Sabra Health Care REIT Inc. files with the SEC, latest filing dated Nov 2, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

SBRA peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
SBRA$919.09M+23.4%$71.51M7.8%$5.51B
WELL$13.79B+39.2%$1.67B12.1%$179.74B
PLD$8.95B+6.7%$3.71B41.5%$120.67B
EQIX$10.06B+11.1%$1.65B16.4%$100.25B
AMT$11.01B+5.3%$3.31B30.1%$87.55B
SPG$7.15B+16.2%$4.51B63.0%$73.91B
DLR$6.34B+12.6%$1.38B21.7%$65.90B
PSA$5.03B+5.2%$1.90B37.8%$63.05B
O$6.21B+10.8%$1.36B21.8%$56.15B

SBRA FAQ

7 questions
  • What is SBRA revenue?
    Sabra Health Care REIT Inc. (SBRA) reported $919.09M of revenue for the twelve months ended Sep 30, 2026. That is up 23.4% from the year before. Revenue for fiscal 2025 was $774.63M.
  • Is SBRA profitable?
    Yes. Sabra Health Care REIT Inc. earned $71.51M in net income for the twelve months ended Sep 30, 2026, a net margin of 7.8%.
  • How much cash and debt does SBRA have?
    Sabra Health Care REIT Inc. reported $36.24M in cash and cash equivalents and $2.44B of debt on its most recent balance sheet in SEC filings.
  • How fast is SBRA revenue growing?
    Sabra Health Care REIT Inc.'s revenue changed +10.2% in fiscal 2025, to $774.63M. Its compound annual growth rate was +5.3% over 5 years and +12.5% over 10 years.
  • What is SBRA earnings per share?
    Diluted earnings per share were $0.28 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did SBRA last report financial results?
    The latest statements here come from Sabra Health Care REIT Inc.'s 10-Q filed on Nov 2, 2026, covering the period ended Sep 30, 2026.
  • Where does this SBRA financial data come from?
    Quantisnow builds these statements from the structured XBRL data Sabra Health Care REIT Inc. files with the SEC. It is provided for information only and is not investment advice.